Teriparatide biosimilar (CinnaGen)

特立帕肽生物类似药（CinnaGen）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide biosimilar (CinnaGen)

Drug Alias Name特立帕肽生物仿制药（CinnaGen）Human parathyroid hormone-(1-34) (CinnaGen)Rec Hu-PTH (CinnaGen)Teriparatide follow-on biologic (CinnaGen)Teriparatide biosimilar - CinnaGen +[7]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionParathyroid hormone replacements

TargetsParathyroid hormone receptor

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsOsteoporosis

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIran

Original Approved Date2013/01/01

Country/TerritoryIran

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesCinnagen

China Registration ClassN/A

Develop Information

Active CompaniesCinnagen

Inactive CompaniesN/A

Active IndicationsOsteoporosis

Inactive IndicationsN/A

Other Information

ATC CodeH05AA02